Melola Discovery

← Melola Discovery

Jurnal SINTA 1

The Association Between Uric Acid and Symmetric Dimethylarginine Levels in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

ACTA MEDICA INDONESIANA · Vol. 54 No. 3 (2022)

ISSN
2338-2732, 0125-9326
Terbit
2022-09-24
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

Background: Uric acid (UA) levels are associated with increased risk of cardiovascular events and mortality in hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients. In a study with a population of healthy young adults and HD there was a correlation between high blood uric acid levels and blood symmetric dimethylarginine (SDMA) level. However, in CAPD population, there are still conflicting data on the mechanism of increased risks related to uric acid levels. This study aimed to assess the association between uric acid levels and SDMA in the subjects undergoing CAPD. Methods: This was a cross – sectional study conducted in all the adults who underwent CAPD for at least three months in tertiary hospital in Jakarta, Indonesia. Subjects already on uric lowering therapy, pregnant or lactating women, and those with a history of malignancy were excluded. Uric acid and SDMA level were measured at the same time patients controlled to outpatient clinic. Bivariate analysis was performed using the Mann – Whitney test and multivariate analysis performed using logistic regression test. Results: A total of 55 subjects were included. The median level of UA was 7.30 + 1.59 mg/dl and 33 subjects (60%) had UA levels of 7 mg/dl or higher. The median SDMA level was 633.73 + 231.54 ng/mL. Subjects with UA levels > 7 mg/dl had significantly higher SDMA levels compared to subjects with UA levels < 7 mg/dl (721.58 + 220.57 vs 501.95 + 182; P < 0.001). The cut – off value of SDMA 536 ng/mL was obtained from the receiver operating characteristic (ROC) curve with sensitivity 81.8%, specificity 63.6%, PPV 77.78% and NPV 73.68%. After fully adjusted with the confounders, the determinant factors in this study were diabetes mellitus (OR: 7.844; CI95%: 1.899 – 32.395: P value: 0.004) and dyslipidemia (OR: 6.440; CI95%: 1.483 – 27.970; P value: 0.013) as risk factors. Conclusion: In CAPD patients, UA levels above 7 mg/dl were associated with increased SDMA levels. This study demonstrates the determinant factors regarding association between UA level and SDMA in CAPD patients were diabetes mellitus and dyslipidemia. The cut – off value of SDMA above 536 ng/mL were significant to increased risk of cardiovascular events.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 285 tautan kepenulisan bersama · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Indonesia
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Rudi PutrantoAfiliasi tidak diketahui24
Edward FaisalAfiliasi tidak diketahui10
Ikhwan RinaldiAfiliasi tidak diketahui10
Siti SetiatiAfiliasi tidak diketahui10
Murdani AbdullahAfiliasi tidak diketahui8
Cleopas Martin RumendeAfiliasi tidak diketahui7
Pringgodigdo NugrohoAfiliasi tidak diketahui5
Iris RengganisAfiliasi tidak diketahui4
Imam SubektiAfiliasi tidak diketahui4
Em YunirUniversity of Indonesia4
Dadang MakmunAfiliasi tidak diketahui4
Dina ElitaAfiliasi tidak diketahui4
Kuntjoro HarimurtiAfiliasi tidak diketahui4
Alvina WidhaniAfiliasi tidak diketahui4
Sally Aman NasutionAfiliasi tidak diketahui4
Ari Fahrial SyamAfiliasi tidak diketahui4
Eka GinanjarAfiliasi tidak diketahui4
Andhika RachmanAfiliasi tidak diketahui4
Idrus AlwiAfiliasi tidak diketahui3
Cosphiadi IrawanAfiliasi tidak diketahui3
Raden Irawati IsmailAfiliasi tidak diketahui3
Yanuar ArdaniAfiliasi tidak diketahui3
Vinandia IrvianitaAfiliasi tidak diketahui3
Achmad FauziAfiliasi tidak diketahui3
Pradana SoewondoAfiliasi tidak diketahui3
Irsan HasanAfiliasi tidak diketahui3
Arif MansjoerAfiliasi tidak diketahui3
Dono AntonoAfiliasi tidak diketahui2
Parlindungan SiregarAfiliasi tidak diketahui2
Ginova NainggolanAfiliasi tidak diketahui2
Mizanul AdliAfiliasi tidak diketahui2
Ratih Arianita AgungAfiliasi tidak diketahui2
Vera AbdullahAfiliasi tidak diketahui2
Petrin R LukmanAfiliasi tidak diketahui2
Suhendro SuwartoAfiliasi tidak diketahui2
Saskia Aziza NursyirwanAfiliasi tidak diketahui2

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Association Between Uric Acid and Symmetric Dimethylarginine Levels in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis</dc:title>
	<dc:creator>Pradwipa, Rizki Yaruntradhani</dc:creator>
	<dc:creator>Hustrini, Ni Made</dc:creator>
	<dc:creator>Hidayat, Rudy</dc:creator>
	<dc:creator>Shatri, Hamzah</dc:creator>
	<dc:subject xml:lang="en-US">uric acid</dc:subject>
	<dc:subject xml:lang="en-US">SDMA</dc:subject>
	<dc:subject xml:lang="en-US">CAPD</dc:subject>
	<dc:description xml:lang="en-US">Background: Uric acid (UA) levels are associated with increased risk of cardiovascular events and mortality in hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients. In a study with a population of healthy young adults and HD there was a correlation between high blood uric acid levels and blood symmetric dimethylarginine (SDMA) level. However, in CAPD population, there are still conflicting data on the mechanism of increased risks related to uric acid levels. This study aimed to assess the association between uric acid levels and SDMA in the subjects undergoing CAPD. Methods: This was a cross – sectional study conducted in all the adults who underwent CAPD for at least three months in tertiary hospital in Jakarta, Indonesia. Subjects already on uric lowering therapy, pregnant or lactating women, and those with a history of malignancy were excluded. Uric acid and SDMA level were measured at the same time patients controlled to outpatient clinic. Bivariate analysis was performed using the Mann – Whitney test and multivariate analysis performed using logistic regression test. Results: A total of 55 subjects were included. The median level of UA was 7.30 + 1.59 mg/dl and 33 subjects (60%) had UA levels of 7 mg/dl or higher. The median SDMA level was 633.73 + 231.54 ng/mL. Subjects with UA levels &amp;gt; 7 mg/dl had significantly higher SDMA levels compared to subjects with UA levels &amp;lt; 7 mg/dl (721.58 + 220.57 vs 501.95 + 182; P &amp;lt; 0.001). The cut – off value of SDMA 536 ng/mL was obtained from the receiver operating characteristic (ROC) curve with sensitivity 81.8%, specificity 63.6%, PPV 77.78% and NPV 73.68%. After fully adjusted with the confounders, the determinant factors in this study were diabetes mellitus (OR: 7.844; CI95%: 1.899 – 32.395: P value: 0.004) and dyslipidemia (OR: 6.440; CI95%: 1.483 – 27.970; P value: 0.013) as risk factors. Conclusion: In CAPD patients, UA levels above 7 mg/dl were associated with increased SDMA levels. This study demonstrates the determinant factors regarding association between UA level and SDMA in CAPD patients were diabetes mellitus and dyslipidemia. The cut – off value of SDMA above 536 ng/mL were significant to increased risk of cardiovascular events.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2022-09-24</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/2013</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 54 No. 3 (2022): Acta Medica Indonesiana; 365</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/2013/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Rizki Yaruntradhani Pradwipa</dc:rights>
</oai_dc:dc>